Ozempic-maker accuses rival of false advertising

Novo Nordisk, the manufacturer of Ozempic, has filed a lawsuit against Eli Lilly, alleging that the company has engaged in false advertising. Novo Nordisk claims that Eli Lilly's ads are misleading, prompting the legal action. Eli Lilly has denied the allegations, disputing Novo Nordisk's claims of false advertising. The lawsuit highlights the competitive tensions between the two pharmaceutical companies.

✦ AI-generated summary